申昊科技(300853.SZ)與天津一號線運營公司達成戰略合作
格隆匯9月23日丨申昊科技(300853.SZ)公佈,公司與天津一號線軌道交通運營有限公司於2021年9月22日簽署了《企業戰略合作協議》。雙方將充分發揮各自的優勢,展開戰略合作事項。
該次與天津一號線軌道交通運營有限公司戰略合作事項是基於在國家戰略方向的大平台下,雙方達成戰略合作共識,充分發揮各自企業的自身優勢,強強聯合,為推動人工智能產業的發展、提升軌道交通行業的智慧運維質量貢獻力量。
公司表示,通過該次戰略合作,相信能夠幫助雙方進一步提升整體運營效率、降低運營成本,實現雙方未來的市場擴張戰略並獲得市場份額,為雙方合作創造更大的商業價值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.